vs
德康医疗（DXCM）与TRINET GROUP, INC.（TNET）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是TRINET GROUP, INC.的1.0倍（$1.3B vs $1.2B），德康医疗同比增速更快（21.6% vs -2.2%），过去两年德康医疗的营收复合增速更高（12.0% vs -0.6%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
TriNet Group, Inc.是一家面向中小企业的专业雇主组织，总部位于加州都柏林，服务员工规模在3至2500人之间的各类机构。可提供薪资管理、健康福利管理服务，还能为客户提供劳动法规合规、风险降低相关咨询，可作为外包人力资源部门为企业分担人事相关事务。
DXCM vs TNET — 直观对比
营收规模更大
DXCM
是对方的1.0倍
$1.2B
营收增速更快
DXCM
高出23.8%
-2.2%
两年增速更快
DXCM
近两年复合增速
-0.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.2B |
| 净利润 | $267.3M | — |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 0.1% |
| 净利率 | 21.2% | — |
| 营收同比 | 21.6% | -2.2% |
| 净利润同比 | 153.6% | — |
| 每股收益（稀释后） | $0.67 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMTNET
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $994.2M | $1.2B | ||
| Q2 24 | $1.0B | $1.2B |
净利润DXCMTNET
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | $34.0M | ||
| Q2 25 | $179.8M | $37.0M | ||
| Q1 25 | $105.4M | $85.0M | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | $45.0M | ||
| Q2 24 | $143.5M | $60.0M |
毛利率DXCMTNET
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMTNET
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 0.1% | ||
| Q3 25 | 20.1% | 4.1% | ||
| Q2 25 | 18.4% | 4.1% | ||
| Q1 25 | 12.9% | 8.9% | ||
| Q4 24 | 17.0% | -2.9% | ||
| Q3 24 | 15.3% | 4.7% | ||
| Q2 24 | 15.7% | 6.5% |
净利率DXCMTNET
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | 2.8% | ||
| Q2 25 | 15.5% | 3.0% | ||
| Q1 25 | 10.2% | 6.6% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | 3.6% | ||
| Q2 24 | 14.3% | 4.9% |
每股收益（稀释后）DXCMTNET
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.02 | ||
| Q3 25 | $0.70 | $0.70 | ||
| Q2 25 | $0.45 | $0.77 | ||
| Q1 25 | $0.27 | $1.71 | ||
| Q4 24 | $0.37 | $-0.44 | ||
| Q3 24 | $0.34 | $0.89 | ||
| Q2 24 | $0.35 | $1.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $287.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $54.0M |
| 总资产 | $6.3B | $3.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMTNET
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $287.0M | ||
| Q3 25 | $1.8B | $321.0M | ||
| Q2 25 | $1.2B | $407.0M | ||
| Q1 25 | $904.9M | $349.0M | ||
| Q4 24 | $606.1M | $360.0M | ||
| Q3 24 | $621.2M | $301.0M | ||
| Q2 24 | $939.2M | $249.0M |
股东权益DXCMTNET
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $54.0M | ||
| Q3 25 | $2.7B | $110.0M | ||
| Q2 25 | $2.6B | $107.0M | ||
| Q1 25 | $2.3B | $63.0M | ||
| Q4 24 | $2.1B | $69.0M | ||
| Q3 24 | $2.0B | $129.0M | ||
| Q2 24 | $2.4B | $100.0M |
总资产DXCMTNET
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $3.8B | ||
| Q3 25 | $7.5B | $3.4B | ||
| Q2 25 | $7.3B | $3.7B | ||
| Q1 25 | $6.8B | $3.8B | ||
| Q4 24 | $6.5B | $4.1B | ||
| Q3 24 | $6.4B | $3.7B | ||
| Q2 24 | $6.8B | $3.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $61.0M |
| 自由现金流经营现金流 - 资本支出 | — | $43.0M |
| 自由现金流率自由现金流/营收 | — | 3.4% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $234.0M |
8季度趋势，按日历期对齐
经营现金流DXCMTNET
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $61.0M | ||
| Q3 25 | $659.9M | $72.0M | ||
| Q2 25 | $303.0M | $75.0M | ||
| Q1 25 | $183.8M | $95.0M | ||
| Q4 24 | $301.4M | $65.0M | ||
| Q3 24 | $199.5M | $84.0M | ||
| Q2 24 | $279.4M | $39.0M |
自由现金流DXCMTNET
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $43.0M | ||
| Q3 25 | $579.4M | $55.0M | ||
| Q2 25 | $208.9M | $57.0M | ||
| Q1 25 | $96.8M | $79.0M | ||
| Q4 24 | $176.8M | $47.0M | ||
| Q3 24 | $88.3M | $59.0M | ||
| Q2 24 | $213.3M | $22.0M |
自由现金流率DXCMTNET
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 3.4% | ||
| Q3 25 | 47.9% | 4.5% | ||
| Q2 25 | 18.1% | 4.6% | ||
| Q1 25 | 9.3% | 6.1% | ||
| Q4 24 | 15.9% | 3.7% | ||
| Q3 24 | 8.9% | 4.8% | ||
| Q2 24 | 21.2% | 1.8% |
资本支出强度DXCMTNET
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 1.4% | ||
| Q3 25 | 6.7% | 1.4% | ||
| Q2 25 | 8.1% | 1.5% | ||
| Q1 25 | 8.4% | 1.2% | ||
| Q4 24 | 11.2% | 1.4% | ||
| Q3 24 | 11.2% | 2.0% | ||
| Q2 24 | 6.6% | 1.4% |
现金转化率DXCMTNET
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | 2.12× | ||
| Q2 25 | 1.69× | 2.03× | ||
| Q1 25 | 1.74× | 1.12× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 1.87× | ||
| Q2 24 | 1.95× | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
TNET
| Insurance Services | $1.1B | 85% |
| Professional Services | $169.0M | 14% |
